Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study

NCT03231930

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +11 more
Locations: Innerspace Collingwood, Victoria, Australia

Health Works Footscray, Victoria, Australia

North Richmond Community Health Richmond, Victoria, Australia

View Trial Details

Completed

Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV

NCT02600325

Conditions: Acquired Immunodeficiency Syndrome, Acute Hepatitis C, Blood-Borne Infections, +21 more
Locations: Institute of Tropical Medicine Antwerp (ITG) Antwerp, Belgium

Erasmus Medical Center (EMC) Rotterdam, South Holland, Netherlands

Onze Lieve Vrouwe Gasthuis (OLVG) Amsterdam, Netherlands

Slotervaart Hospital Amsterdam, Netherlands

View Trial Details

Completed

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults

NCT03425149

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +7 more
Locations: New Orleans Center for Clinical Research Knoxville, Tennessee, United States

View Trial Details

Completed

Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)

NCT02115321

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details

Completed

KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C

NCT03995485

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Chinese PLA 302 Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing Youyi Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing You'an Hospital Beijing, Beijing Municipality, China

Capital Medical University Affiliated Beijing Ditan Hospital Beijing, Beijing Municipality, China

View all 19 locations

View Trial Details

Completed

Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children

NCT01391819

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: GSK Investigational Site Fortaleza, Ceará, Brazil

View Trial Details

Completed

The Boceprevir and Sildenafil Pharmacokinetics Study

NCT01499498

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Imperial College Healthcare NHS Trust London, United Kingdom

View Trial Details

Completed

The Effectiveness of Paritaprevir/Ritonavir - Ombitasvir, ± Dasabuvir, ± Ribavirin in France

NCT02618928

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Hopital Saint Joseph /ID# 144927 Marseille, Bouches-du-Rhone, France

Hopital Saint Joseph /ID# 145560 Marseille, Bouches-du-Rhone, France

Hopital Saint Joseph /ID# 145571 Marseille, Bouches-du-Rhone, France

CHR Orleans - Hopital de la Source /ID# 147250 Orléans, Centre-Val de Loire, France

View all 70 locations

View Trial Details

Completed

A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection

NCT02498015

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: The Kirby Institute, University of New South Wales Australia Sydney, New South Wales, Australia

View Trial Details

Completed

The Pharmacokinetics of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Participants With Renal Insufficiency (MK-5172-050)

NCT01937975

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +23 more
Locations: Not specified

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions